Reliability of cardiotocography in predicting baby's condition at birth P CURZEN, J S BEKIR, D G McLINTOCK, M PATEL Abstract A prospective study of 6825 labours was undertaken to determine the relation between the Apgar scores of the babies at one minute and the cardiotocograph tracing in labour. The sensitivity of an abnormal tracing was 35 2% for babies who needed intermittent positive pressure ventilation and 20 0% for babies who did not but who had Apgar scores of less than 7. The sensitivity of an abnormal tracing for all babies with an Apgar score of less than 7 was 23 2%. The positive predictive value of an abnormal tracing was 8-7% for babies who 18 7% for babies who did not but who had an Apgar score of less than 7. The positive predictive value of an abnormal tracing was 27-4% for all babies with an Apgar score of less than 7. The specificity of the tracing was 93 4% for babies with an Apgar score of 7 or over.
The relatively high incidence of false positive predictions might be explained on the grounds that abnormalities in the cardiotocograph tracing are a more sensitive indicator of hypoxia than the Apgar score. False negative predictions might have been due to adverse factors other than hypoxia-for example, fetal trauma, compression of the head, infection, and analgesia in labour.
These findings suggest that the current overdependence on fetal monitoring by cardiotocography alone should be examined and that other reliable indicators for non-hypoxic fetal distress should be sought.
Introduction
Continuous monitoring of the fetal heart rate in labour is now widespread, but the fetal benefits of this have been questioned.' Earlier papers reporting the results of randomised controlled trials showed that continuous monitoring was associated with a significant increase in the incidence of operative deliveries but there was no definite fetal advantage. 2 We report a prospective study of 6825 consecutive labours in which we compared the clinical condition of babies who were delivered operatively because of fetal distress diagnosed by cardiotocography and babies whose cardiotocograph tracing had been normal.
Patients and methods
We analysed the computerised results of 6825 consecutive labours. Some mothers with uncomplicated obstetric histories and pregnancies were monitored only by intermittent auscultation of the fetal heart at intervals of 15 minutes and were not considered further. All the rest were monitored continuously by cardiotocography, the recordings being interpreted at the time by the obstetric registrar on duty. Operative delivery for fetal distress was performed if the cardiotocograph tracing showed late decelerations accompanied by baseline tachycardia or loss of baseline variation, or both. 6 The clinical condition of the newborn babies was assessed by the Apgar score at one minute and by the need for intermittent positive pressure ventilation. The data were analysed by the department of computer medicine at Westminster Hospital.
Results
From 1 January 1978 to 31 December 1982 there were 6825 deliveries. Of these, 683 were monitored only by intermittent auscultation of the fetal heart and were not studied further. Continuous monitoring of the fetal heart rate by cardiotocography was used in 5962 labours (8744%). Table I shows the relation between the cardiotocograph tracing in labour and the condition of the baby at birth. In 492 labours (8-3°0e ) operative delivery was undertaken because of an abnormal tracing. produce an abnormal tracing because they are not necessarily associated with fetal acidosis. 9 Our study produced some evidence in support of this. In those cases in which the cardiotocograph tracing was normal throughout labour there was an appreciably larger proportion of babies with Apgar scores of less than 7 or requiring intermittent positive pressure ventilation among those delivered operatively than among those delivered normally. The operative deliveries were undertaken for failure to advance in labour due to uterine, pelvic, or fetal factors, the fetal factors being either malpresentation or malposition.
We applied the Apgar score in our study because it remains widely used as a simple clinical index of the condition and behaviour of newborn babies. So far, nothing better has been found to replace it.
This study showed that both the sensitivity and the predictive value of an abnormal cardiotocograph tracing in labour for babies born with an Apgar score of less than 7 were poor, whether or not the babies required intermittent positive pressure ventilation. A normal tracing was obtained in 77% of all babies with an Apgar score of less than 7 and 65% of those who needed intermittent positive pressure ventilation. Cardiotocography gave a false positive prediction in 73% and a false negative prediction in 8% of all babies.
The positive predictive value of cardiotocography was significantly better in those babies delivered by emergency caesarean section compared with those delivered by forceps. Most caesarean sections were performed in the first stage of labour, and all forceps deliveries were performed in the second stage. We do not think that the assessment of the cardiotocograph tracings was different for the two groups, which suggests that cardiotocography is more reliable in the first stage than in the second stage of labour.
The Apgar score will probably continue to be widely used as a clinical criterion for a baby's condition at birth. As factors other than hypoxia may affect it we should not expect it to be closely correlated with intrapartum indicators of hypoxia. It follows that we should re-examine the current overdependence on fetal monitoring by cardiotocography and seek other reliable indicators for non-hypoxic fetal distress.
SHORT REPORTS
Generalised epileptic fits in renal transplant recipients given cyclosporin A Cyclosporin A is widely used to induce immunosuppression after organ transplantation. Reported neurological side effects include tremor, ataxia, confusion, paraparesis, and quadriparesis.' 2 Epileptic fits have not been reported in patients given renal transplants but may occur after bone marrow transplantation.3 In our unit cyclosporin A (5-10 mg/kg/day) is administered 12 hourly to achieve predose whole blood concentrations of 200-400 jig/l, as measured by radioimmunoassay.
Case reports
Case 1-Thirty days after cadaveric renal transplantation this patient developed right sided headache and blurring of vision and then had three generalised epileptic fits. On recovery neurological examination showed nothing abnormal. He was metabolically stable (plasma concentration of sodium 138 mmol(mEq)/l, potassium 4-8 mmol(mEq)/l, calcium 2-24 mmol/l (9-0 mg/100 ml), bicarbonate 18 mmol(mEq)/l, urea 33 mmol/l (199 mg/ 100 ml), creatinine 345 stmol/l (3-9 mg/100 ml)). No acute change in renal function was noted. A computed tomogram (CT) of the brain was normal.
Cyclosporin A concentration was 584 Hgll.
Case 2-Four days after cadaveric renal transplantation this patient reported visual flashes and then had four generalised epileptic fits. On recovery neurological findings were normal. His metabolic state was stable (plasma concentration of sodium 139 mmol/l, potassium 4-9 mmol/l, bicarbonate 22 mmol/l, urea 36 mmol/l (217 mg/100 ml), creatinine 892 fimol/l (10-1 mg/100 ml), calciuim 2-3 mmol/l (9-2 mg/100 ml)). Electroencephalography showed a normal rhythm. Cyclosporin A concentration was 1075 1eg/l. Case 3-Two months after a second transplant operation this patient felt unwell and saw rainbow bands; she then began jerking her head to the left and had five generalised epileptic fits. On recovery neurological examination elicited weakness of the left side of her mouth and exaggerated reflexes on the right side with clonus of the knee. These signs cleared over the next two days. She was metabolically stable (plasma concentration of sodium 135 mmol/l, potassium 4-2 mmol/l, urea 56 mmol/l (337 mg/100 ml), creatinine 467 /Lmol/l (5 3 mg/l00 ml), calcisim 2-55 mrnol/l (10-2 mg/100 ml)).
CT showed a low density area in the white matter of the right parietal lobe, which had disappeared at the next examination one week later. Cyclosporin A concentration was 533 Hg/l.
COMMON CLINICAL FEATURES
Each of these patients had generalised epileptic fits for the first time in their lives while receiving cyclosporin A after renal transplantation. Phenytoin was prescribed as an anticonvulsant measure and the cyclosporin A reduced to achieve blood concentrations of 200-400 Htg/l (recommended range). The patients had no further fits. None had an acute rejection episode, although the third patient, whose renal transplant function was poor initially, required chronic ambulatory peritoneal dialysis for two months after the episode. One month later her transplanted kidney was functioning well. These patients were receiving no other drugs which might have been responsible for the fits. Their blood pressures were stable and there was no evidence of hypertensive encephalopathy. The patients were followed up for four, 18, and three months, respectively; there was no recurrence of fits and all three transplants were functioning well (serum creatinine concentration < 300 ,umol/l (< 3-4 mg/100 ml)).
When the epileptic fits occurred in cases 1 and 2 an initial diagnosis of rejection was made, but this was not proved.
Comment
Epileptic fits in patients with transplants may be caused by infection, rejection, or metabolic upset. So far as we could tell these were ruled out in our patients: all had normal cerebrospinal fluid findings, the serial serum viral titres did not rise, and their weight and metabolic states were stable. Space occupying lesions and other organic lesions of the central nervous system were also unlikely, as CT scans and electroencephalograms showed no persistent abnormality. Epileptic fits after renal transplantation may occur due to encephalopathy associated with an acute rejection episode,4 but none of our patients had acute rejection at the time.
Epileptic fits in the absence of a conventional cause in three of our patients over 18 months led us to suspect that cyclosporin A might be responsible or at least a predisposing factor. Although epileptic fits caused by cyclosporin A have not been reported in renal transplant recipients, epileptic fits have been reported in association with cyclosporin A given ofter bone marrow transplantation.3
